Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01176461
What this trial is testing

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 127
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05239650
What this trial is testing

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

Who this might be right for
CRC
Shanghai Henlius Biotech 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07524413
What this trial is testing

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 514
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686588
What this trial is testing

Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent or Metastatic Head and Neck Carcinoma
Biying Chen 20
Testing effectiveness (Phase 2)Looking for participantsNCT06580574
What this trial is testing

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Who this might be right for
Gastric CancerColon CancerMSI-H+1 more
Peking University 34
Large-scale testing (Phase 3)Looking for participantsNCT04365036
What this trial is testing

A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 207
Testing effectiveness (Phase 2)Ended earlyNCT03288545
What this trial is testing

Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Global Development, Inc. 348
Testing effectiveness (Phase 2)Active Not RecruitingNCT03016871
What this trial is testing

Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 78
Testing effectiveness (Phase 2)Study completedNCT02759575
What this trial is testing

Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Vinita Takiar 9
Testing effectiveness (Phase 2)UnknownNCT04029181
What this trial is testing

ImmunoPET With an Anti-CD8 Imaging Agent

Who this might be right for
Metastatic CancerUnresectable Malignant Neoplasm
University Medical Center Groningen 47
Early research (Phase 1)Ended earlyNCT04156100
What this trial is testing

A Study in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Agenus Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT06008054
What this trial is testing

SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors

Who this might be right for
Esophageal CancerGastric CancerColorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 376
Testing effectiveness (Phase 2)WithdrawnNCT05982522
What this trial is testing

IN10018 Combination Therapy in Previously-treated Solid Tumors

Who this might be right for
Solid Tumor
InxMed (Shanghai) Co., Ltd.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04043195
What this trial is testing

Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC

Who this might be right for
Advanced NSCLC
Hatim Husain 30
Testing effectiveness (Phase 2)UnknownNCT04767295
What this trial is testing

Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hunan Cancer Hospital 28
Testing effectiveness (Phase 2)UnknownNCT03973112
What this trial is testing

A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Henlius Biotech 123
Testing effectiveness (Phase 2)UnknownNCT04014101
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06349980
What this trial is testing

Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Henlius Biotech 117
Not applicableLooking for participantsNCT07400354
What this trial is testing

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Who this might be right for
Gastric CancerGut Microbiota
Fudan University 300
Testing effectiveness (Phase 2)Looking for participantsNCT06959550
What this trial is testing

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
M.D. Anderson Cancer Center 90
Next Page